
Opinion|Videos|February 14, 2025
Treatment approach for a mother experiencing PPD already on SSRI
Melanie Barrett, MD; Anita Clayton, MD, and Carmen Kosicek, MSN, PMHNP-BC, discuss how optimizing SSRI dosage, potentially augmenting with another medication class, and intensifying psychosocial support helps address breakthrough PPD symptoms in mothers with partial response to current SSRI treatment.
Advertisement
Episodes in this series

Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves sNDA of Caplyta for the Prevention of Relapse in Schizophrenia
2
Accelerated FDA Action for Psychedelics: Insights From Daniel R. Karlin, MD, MA
3
FDA Fast-Tracks Psychedelic Therapies for Depression, PTSD, and Alcohol Use Disorder
4
A Review of Data on AXS-05 for Alzheimer Disease Agitation in Advance of Next Week's PDUFA Date
5





